65 results
8-K
EX-4.3
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant … the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant
8-K
EX-4.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation … (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
for cash in the amount of the Black-Scholes Value (as defined in each warrant) of the unexercised portion of the Common Warrants concurrently … proportion), at the Black Scholes Value of the unexercised portion of the Common Warrant that is being offered and paid to the holders of our common
8-K
EX-99.1
86zjc
14 Dec 22
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
11:22am
8-K
EX-99.2
igudc
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-10.1
33gpp 5ztnwhd73ywry
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
osbq0dfnep2uw4ut9h
24 Mar 22
Prospectus supplement for primary offering
4:15pm
424B5
ec7ii5
20 Aug 21
Prospectus supplement for primary offering
4:46pm